Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial.

類似資料

• Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402].
  著者:: Iro, M, 等
  出版事項: (2017)
• Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
  著者:: Snape, M, 等
  出版事項: (2015)
• 4CMenB journey to the 10-year anniversary and beyond
  著者:: Véronique Abitbol, 等
  出版事項: (2024-12-01)
• Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
  著者:: Federico Martinón-Torres, 等
  出版事項: (2019-12-01)
• Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
  著者:: Rollier, CS, 等
  出版事項: (2022)